- Home
- DVA vs MBLY Comparison
DVA vs MBLY Comparison
Compare DVA & MBLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- MBLY
- Stock Information
- Founded
- DVA 1994
- MBLY 1999
- Country
- DVA United States
- MBLY Israel
- Employees
- DVA N/A
- MBLY N/A
- Industry
- DVA Misc Health and Biotechnology Services
- MBLY Computer Software: Prepackaged Software
- Sector
- DVA Health Care
- MBLY Technology
- Exchange
- DVA Nasdaq
- MBLY Nasdaq
- Market Cap
- DVA 9.7B
- MBLY 11.2B
- IPO Year
- DVA 1995
- MBLY 2022
- Fundamental
- Price
- DVA $130.10
- MBLY $13.78
- Analyst Decision
- DVA Hold
- MBLY Buy
- Analyst Count
- DVA 3
- MBLY 17
- Target Price
- DVA $154.67
- MBLY $20.06
- AVG Volume (30 Days)
- DVA 663.6K
- MBLY 4.1M
- Earning Date
- DVA 10-28-2025
- MBLY 10-30-2025
- Dividend Yield
- DVA N/A
- MBLY N/A
- EPS Growth
- DVA 8.72
- MBLY N/A
- EPS
- DVA 10.20
- MBLY N/A
- Revenue
- DVA $13,161,328,000.00
- MBLY $1,920,000,000.00
- Revenue This Year
- DVA $5.96
- MBLY $13.66
- Revenue Next Year
- DVA $3.54
- MBLY $9.95
- P/E Ratio
- DVA $12.76
- MBLY N/A
- Revenue Growth
- DVA 5.09
- MBLY 4.07
- 52 Week Low
- DVA $126.07
- MBLY $10.62
- 52 Week High
- DVA $179.60
- MBLY $22.51
- Technical
- Relative Strength Index (RSI)
- DVA 38.72
- MBLY 43.75
- Support Level
- DVA $131.77
- MBLY $13.56
- Resistance Level
- DVA $137.58
- MBLY $14.26
- Average True Range (ATR)
- DVA 2.61
- MBLY 0.48
- MACD
- DVA -0.54
- MBLY -0.00
- Stochastic Oscillator
- DVA 4.45
- MBLY 19.88
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.